Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Tormentic acid is a triterpene that has been found in P. frutescens and has diverse biological activities, including anti-inflammatory, anticancer, antioxidative, and antidiabetic properties.1,2,3 It reduces hydrogen peroxide-induced increases in inducible nitric oxide synthase (iNOS) and NADPH oxidase (NOX1), as well as the production of TNF-α, IL-6, and IL-1β in rat vascular smooth muscle cells (RVSMCs) when used at concentrations of 12.5, 25, and 50 µM.2 Tormentic acid (25 and 50 µM) decreases hydrogen peroxide-induced generation of reactive oxygen species (ROS) in RVSMCs. It reduces ear edema induced by phorbol 12-myristate 13-acetate (TPA; Item No. 10008014) in mice (ID50 = 0.03 mg/ear).1 Topical application of tormentic acid (1.7 nmol) reduces the number of papillomas formed per mouse in a DMBA-TPA two-stage model of mouse skin carcinogenesis. It also reduces increases in blood glucose, insulin, and leptin levels, as well as hepatic triglyceride levels, in mice fed a high-fat diet in a model of diabetes and hyperlipidemia when administered at doses of 60 and 120 mg/kg per day.3
WARNING This product is not for human or veterinary use.
1. Triterpene acids from the leaves of Perilla frutescens and their anti-
2. Tormentic acid inhibits H2O2-
3. Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-